Universal Biosensors Inc - Asset Resilience Ratio

Latest as of June 2025: 14.72%

Universal Biosensors Inc (UBI) has an Asset Resilience Ratio of 14.72% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See UBI current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$2.20 Million

≈ $1.56 Million USD Cash + Short-term Investments

Total Assets

AU$14.94 Million

≈ $10.57 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2007–2024)

This chart shows how Universal Biosensors Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see UBI total assets.

Liquid Assets Composition Over Time

This chart breaks down Universal Biosensors Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Universal Biosensors Inc total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$2.20 Million	14.72%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$2.20 Million	14.72%

Asset Resilience Insights

Moderate Liquidity: Universal Biosensors Inc has 14.72% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Universal Biosensors Inc Industry Peers by Asset Resilience Ratio

Compare Universal Biosensors Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Eurobio Scientific SA PA:ALERS	Medical Devices	10.52%
Profound Medical Corp TO:PRN	Medical Devices	67.66%
EBR Systems Inc AU:EBR	Medical Devices	54.70%
Epitomee Medical Ltd TA:EPIT	Medical Devices	0.24%
Cleo Diagnostics Ltd AU:COV	Medical Devices	94.64%
Aligned Genetics Inc KQ:238120	Medical Devices	2.22%

Annual Asset Resilience Ratio for Universal Biosensors Inc (2007–2024)

The table below shows the annual Asset Resilience Ratio data for Universal Biosensors Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	33.06%	AU$8.54 Million ≈ $6.05 Million	AU$25.84 Million ≈ $18.28 Million	-1.22pp
2023-12-31	34.28%	AU$10.28 Million ≈ $7.27 Million	AU$29.97 Million ≈ $21.21 Million	-22.01pp
2022-12-31	56.30%	AU$25.98 Million ≈ $18.38 Million	AU$46.15 Million ≈ $32.65 Million	+21.87pp
2021-12-31	34.42%	AU$15.32 Million ≈ $10.84 Million	AU$44.50 Million ≈ $31.49 Million	-7.37pp
2020-12-31	41.79%	AU$23.56 Million ≈ $16.67 Million	AU$56.38 Million ≈ $39.89 Million	-6.45pp
2019-12-31	48.24%	AU$30.23 Million ≈ $21.39 Million	AU$62.66 Million ≈ $44.34 Million	+31.39pp
2018-12-31	16.86%	AU$11.80 Million ≈ $8.35 Million	AU$69.98 Million ≈ $49.51 Million	-39.94pp
2017-12-31	56.80%	AU$26.27 Million ≈ $18.59 Million	AU$46.26 Million ≈ $32.73 Million	+15.98pp
2016-12-31	40.81%	AU$20.40 Million ≈ $14.44 Million	AU$49.99 Million ≈ $35.37 Million	+40.63pp
2011-12-31	0.18%	AU$83.34K ≈ $58.97K	AU$45.22 Million ≈ $31.99 Million	-4.73pp
2007-12-31	4.92%	AU$3.14 Million ≈ $2.22 Million	AU$63.86 Million ≈ $45.18 Million	--

pp = percentage points

About Universal Biosensors Inc

AU:UBI Australia Medical Devices

Market Cap

$2.95 Million

AU$4.17 Million AUD

Market Cap Rank

#29594 Global

#1677 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.01

All Time High

AU$1.00